Prolia News
Most Popular Prolia Story
Amgen's D-mab one step closer to EU approval
Amgen has won a big endorsement of its osteoporosis drug denosumab, which will be marketed as Prolia. The Committee for Medicinal Products for Human Use of the European Medicines Agency voted to Read more...
Latest Headlines
- June 2, 2010
- December 18, 2009
- October 22, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
